Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Magenta Therapeutics stock
Learn how to easily invest in Magenta Therapeutics stock.
Magenta Therapeutics Inc is a biotechnology business based in the US. Magenta Therapeutics shares (MGTA) are listed on the NASDAQ and all prices are listed in US Dollars. Magenta Therapeutics employs 70 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Magenta Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MGTA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Magenta Therapeutics stock price (NASDAQ: MGTA)Use our graph to track the performance of MGTA stocks over time.
Magenta Therapeutics shares at a glance
|Latest market close||$1.34|
|52-week range||$0.92 - $8.49|
|50-day moving average||$1.75|
|200-day moving average||$2.47|
|Wall St. target price||$5.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.33|
Buy Magenta Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Magenta Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Magenta Therapeutics price performance over time
|1 week (2022-09-22)||-6.94%|
|1 month (2022-08-29)||-22.09%|
|3 months (2022-06-29)||15.52%|
|6 months (2022-03-29)||-60.36%|
|1 year (2021-09-28)||-81.72%|
|2 years (2020-09-29)||-80.41%|
|3 years (2019-09-27)||9.63|
|5 years (2017-09-25)||N/A|
Magenta Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-25.38%|
|Return on equity TTM||-45.45%|
|Market capitalisation||$83 million|
TTM: trailing 12 months
Magenta Therapeutics share dividends
We're not expecting Magenta Therapeutics to pay a dividend over the next 12 months.
Magenta Therapeutics share price volatility
Over the last 12 months, Magenta Therapeutics's shares have ranged in value from as little as $0.92 up to $8.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Magenta Therapeutics's is 2.0763. This would suggest that Magenta Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Magenta Therapeutics overview
Magenta Therapeutics, Inc. , a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that cause acute myeloid leukemia and myelodysplastic syndromes, which is under Phase I/II clinical trial; CD45-antibody drug conjugate that targets HSCs and immune cells, which is in investigational new drug application enabling studies for potential use as a single-agent in autoimmune diseases and hematology-oncology transplants; and MGTA-145 that is in Phase II clinical trial for use in autologous and allogeneic transplants. The company also has a cell therapy program, E478, which is a small molecule aryl hydrocarbon receptor antagonist for stem cell-based gene therapy and genome editing. Magenta Therapeutics, Inc. has a research and clinical collaboration agreement with AVROBIO, Inc. for the treatment of lysosomal storage disorders; and Beam Therapeutics, Inc.
Magenta Therapeutics in the news
Australian Billionaire Kerr Neilson is Selling These 15 Stocks
Frequently asked questionsWhat percentage of Magenta Therapeutics is owned by insiders or institutions?
Currently 7.974% of Magenta Therapeutics shares are held by insiders and 71.231% by institutions. How many people work for Magenta Therapeutics?
Latest data suggests 70 work at Magenta Therapeutics. When does the fiscal year end for Magenta Therapeutics?
Magenta Therapeutics's fiscal year ends in December. Where is Magenta Therapeutics based?
Magenta Therapeutics's address is: 100 Technology Square, Cambridge, MA, United States, 02139 What is Magenta Therapeutics's ISIN number?
Magenta Therapeutics's international securities identification number is: US55910K1088 What is Magenta Therapeutics's CUSIP number?
Magenta Therapeutics's Committee on Uniform Securities Identification Procedures number is: 55910K108
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert